Kala Bio (KALA) Prix de l'Action, Cotation, Actualités et Historique | Benzinga

Kala Bio Inc (KALA) Prix de l'Action, Cotation, Actualités et Historique

KALANASDAQ

Trade with Public

Trade with Public

$0.1990

0.01357.28%

Dern. MÀJ: Oct 22, 7:26 PM

$0.1990

0.01357.28%

AperçuActualités Prévisions de résultats Événements Objectifs de cours Données financières Sentiment Actionnariat Comparer Rapport sur les stocks

© 2026 Benzinga | All Rights Reserved

Statistiques Clés

Ouverture

-

Clôture

-

Volume / Moy.

0 / 1.46M

Fourchette Journalière

- - -

Plage 52 Sem.

0.11 - 95.50

Capitalisation Boursière

$3.85M

Ratio P/E

-

Rendement des Dividendes

-

Échange

NASDAQ

RSI

23

Intérêt à Découvert

7.06%

Jours pour Couvrir

1

Actualités Récentes de KALA BIO Inc

Why FingerMotion Shares Are Trading Higher By Around 18%; Here Are 20 Stocks Moving Premarket

FingerMotion jumped 18.1% premarket after agreeing to buy Newbit Technology for $2.3M cash; NewGenIvf led gainers at 187.2%, while Silexion fell 16.6%.

Avi Kapoor

KALA Bio (KALA) Shares Soar 57% After Hours: Here's Why

KALA Bio shares surge after hours after signing an LOI to acquire a nationwide telehealth platform.

Tanya Rawat

Dow Dips Over 300 Points; Medtronic Shares Gain After Upbeat Q1 Earnings

U.S. stocks traded lower this morning, with the Dow Jones index falling more than 300 points on Tuesday. Following the market opening Tuesday, the Dow traded down 0.58% to 52,876.43 while the NASDAQ dipped 1.40% to

Avi Kapoor

Top 3 Health Care Stocks Which Could Blast Off This Quarter

Undervalued companies in health care sector with low RSI values present buying opportunity: PepGen Inc (PEPG), KALA BIO Inc (KALA), Viridian Therapeutics Inc (VRDN)

Avi Kapoor

EXCLUSIVE: Penny Stock Kala Bio Transitions To Revenue Model With AI Platform Launch

Kala Bio launches BIRA AI agent for biotech research, marking a shift to commercial deployment and a potential recurring revenue model.

Vandana Singh

Données financières

Trimestriel

Annuel

Nom

Revenu Changement
Brut Changement
EBITDA Changement
EBIT Changement
Bénéfices Changement

Flux de Trésorerie

Flux de Trésorerie Opérationnel (TTM)

-19.86M

Flux de Trésorerie d'Investissement (TTM)

-7.00M

Flux de Trésorerie de Financement (TTM)

-4.85M

Flux de Trésorerie Libre (TTM)

-19.88M

Dépenses en Capital (TTM)

-

Variation Nette de la Trésorerie (TTM)

-31.71M

Évaluation et prévisions des analystes

4.7

Achat fort

Achat fort

Acheter

Conserver

Vendre

Vente forte

Métriques de Valorisation

Valeur Entreprise

-$3.96M

Ratio P/E (TTM)

-

Ratio P/E (FWD)

-

Ratio PEG (TTM)

-

Ratio P/S (TTM)

-

Ratio P/B (TTM)

0.40

Rendement des Bénéfices % (TTM)

-5048.39%

Rendement des Bénéfices % (FWD)

-

EV / EBITDA (TTM)

-

Prix / EBITDA (TTM)

-

Prix / Flux de Trésorerie Libre (TTM)

-

Valeur Comptable / Action

$0.47

Dette Entreprise

Dette Totale

-

Dette à Long Terme

-

Émission de Dette à Long Terme (TTM)

-

Remboursement de la Dette à Long Terme (TTM)

-$19.95M

Trésorerie Totale

$229.00K

Dette sur Capitaux Propres

-

Émission de Dette (TTM)

-$19.95M

Remboursement de la Dette (TTM)

-$19.95M